Clinical Trial Update: A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study assessing safety, tolerability and pharmacokinetics of PF-04455242 across single rising doses in healthy adult volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• PF-04455242 (PF-04455242)

Snippet

Sponsor: Pfizer | Conditions: Bipolar Depression | Phase 1 | Status: COMPLETED